Latest News

Novavax’s Covid-19 vaccine shows promising immune response, early data show



A potential Covid-19 vaccine from the biotech company Novavax showed a promising immune response in a small, early trial, but not without a high rate of mostly mild side effects.

The results, published Tuesday, are the latest encouraging sign in the global effort to develop a vaccine for the novel coronavirus, which has killed nearly 700,000 people around the world. But the Novavax data, much like results recently published by Moderna and AstraZeneca, are too preliminary to draw any conclusions about how well the vaccine might protect against Covid-19, experts said.

Read the rest…

Source link

Related posts

Study: Teen, Young Adult Overdose Attempts Soar

Newsemia

Medical News Today: Diez causas comunes de la mastalgia

Newsemia

Helping Asian-Americans fight their hidden heart risks

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World